Hogan to Retire from Sigma-Aldrich, Qiagen Names VP of MDx, Casper Gets Promoted at Thermo Fisher, and More | GenomeWeb
NEW YORK (GenomeWeb News) - Sigma-Aldrich’s chief administrative officer and chief financial officer Michael Hogan plans to retire sometime this summer, after the company names his successor, Sigma-Aldrich said this week. Hogan said he is leaving the company to pursue volunteer and civic activities. The company has begun a search for his replacement.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.